Drug Pipeline

Etrumadenant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
5
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT05633667
Study of Novel Treatment Combinations in Patients With Lung Cancer		 overall status: "Recruiting" → "Active Not Recruiting"
2026-06-02 NCT05633667
Study of Novel Treatment Combinations in Patients With Lung Cancer		 Enrollment reduced: 270 -> 192 participants
2026-06-02 NCT05633667
Study of Novel Treatment Combinations in Patients With Lung Cancer		 Trial sites reduced: 100 -> 89 locations
Active Studies by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06048484 Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma Recruiting
NCT03821246 Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer… Prostate Adenocarcinoma Recruiting
NCT05335941 A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928… Urothelial Carcinoma Active, Not Recruiting
NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer Lung Cancer Active, Not Recruiting
NCT04791839 Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and… Non Small Cell Lung Cancer Active, Not Recruiting
Sponsors Running Etrumadenant Trials
David Oh (1) Washington University School of Medicine (1) M.D. Anderson Cancer Center (1) Gilead Sciences (1) Gulam Manji (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Prostate Cancer (1) Bladder Cancer (1) Pancreatic Cancer (1)
Get alerts when Etrumadenant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free